Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $466.01
-
Support level$432.65
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)76.0
- AMGN is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- With a 59.7 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Up 6.1 percent, AMGN is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $296.30 | $466.01 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $374.79 | $419.96 | $431.20 | $445.99 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.5%
-
In the next month13.9%
-
In the next year57.2%
| Period | Value |
|---|---|
| Historical (5 year) | 24.8% |
| Last month | 29.6% |
| Current estimate | 24.1% |
| Next month forecast | 24.6% |